CYR61: a new measure of lung cancer outcome.
Mori A, Desmond JC, Komatsu N, O'Kelly J, Miller CW, Legaspi R, Marchevsky AM, McKenna RJ Jr, Koeffler HP.
Mori A, et al.
Cancer Invest. 2007 Dec;25(8):738-41. doi: 10.1080/02770900701512597.
Cancer Invest. 2007.
PMID: 18058471